Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
Tziomalos Konstantinos
First Propedeutic Department Of Internal Medicine Aristotle University Of Thessaloniki Ahepa Hospita
-
Kandaraki Eleni
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
Koiou Ekaterini
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
Panidis Dimitrios
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
Dinas Konstantinos
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
Kalaitzakis Emmanuil
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
Katsikis Ilias
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aris
-
KANDARAK Eleni
Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokration Hospital
-
TSOURDI Elena
Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokration Hospital
-
MAVRIDIS Stylianos
Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokration Hospital
-
Tsourdi Elena
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aristotle University Of Thessaloniki Hippokration Hospital
-
Mavridis Stylianos
Division Of Endocrinology And Human Reproduction Second Department Of Obstetrics And Gynecology Aristotle University Of Thessaloniki Hippokration Hospital
関連論文
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome
- Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome